AI Article Synopsis

  • Acquired TTP patients don’t show major coagulation or fibrinolysis abnormalities, making the extent unclear.
  • The study examined 138 TTP patients and 46 septic DIC patients, comparing blood counts and coagulation parameters.
  • Significant differences were found, such as lower platelet counts in TTP and higher prothrombin time in DIC, suggesting that specific lab tests can help differentiate between the two conditions.

Article Abstract

Introductions: Patients with acquired thrombotic thrombocytopenic purpura (TTP) show no severe abnormalities in coagulation or fibrinolysis. However, the exact extent of the abnormalities is unclear.

Materials And Methods: This study analyzed 138 patients with acquired TTP and 46 patients with septic disseminated intravascular coagulation (DIC) who were included in a Japanese registry. Complete blood cell counts and 8 coagulation or fibrinolysis parameters were compared between the 2 groups.

Results: Platelet counts in the acquired TTP group were significantly lower than those in the septic DIC group (P < .001). The international normalized ratio of prothrombin time and the activated partial thromboplastin time in the septic DIC group were significantly higher and longer, respectively, than those in the acquired TTP group (P < .01). The antithrombin (AT) values were significantly lower in the septic DIC group than in the acquired TTP group (P < .001), the latter of which were almost normal. Although both groups revealed elevations of fibrinogen degradation product (FDP) and D-dimer, these levels were significantly higher in the septic DIC group than in the acquired TTP group (P < .001). Of 138 patients with acquired TTP, 25 (18.1%) were diagnosed with septic DIC by the diagnostic criteria of the Japanese Ministry Health, Labour and Welfare, and 78 (56.5%) by those of the Japanese Association of Acute Medicine. Receiver operating characteristic curve analysis showed that acquired TTP could be diagnosed based on severe thrombocytopenia (<20 × 10/L), normal AT level (>87%), and mildly elevated FDP (<23 µg/mL).

Conclusions: Our results indicate that 3 routine laboratory tests could differentiate between acquired TTP and septic DIC.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0885066619899637DOI Listing

Publication Analysis

Top Keywords

acquired ttp
28
septic dic
20
ttp group
16
dic group
16
coagulation fibrinolysis
12
patients acquired
12
group 001
12
acquired
9
acquired thrombotic
8
thrombotic thrombocytopenic
8

Similar Publications

Background: Several factors are frequently considered for outcome prediction rin stroke patients. We assessed the value of digital subtraction angiography (DSA)-based brain perfusion measurements after mechanical thrombectomy (MT) for outcome prediction in acute ischaemic stroke.

Methods: From DSA image data (n = 90; 38 females; age 73.

View Article and Find Full Text PDF

Acquired thrombotic thrombocytopenic purpura (acquired TTP) is a rare clinical syndrome caused by a decreased ADAMST13 activity, leading to systemic microvascular thrombotic events, with high mortality rates when the diagnosis and treatment are delayed. The authors report an acquired TTP in a patient with cerebrovascular disease. The aim is to emphasize the importance of considering atypical acquired TTP clinical presentations in order to optimize diagnostic and treatment approaches, minimize possible sequels, and improve the prognosis.

View Article and Find Full Text PDF

[100 years thrombotic thrombocytopenic purpura (TTP) - lessons learned?].

Dtsch Med Wochenschr

November 2024

Klinik für Innere Medizin I - Abteilung für Hämatologie und Hämostaseologie, Medizinische Universität Wien, Österreich.

100 years ago Dr. Eli Moschcowitz described the first case of thrombotic thrombocytopenic purpura. For many decades there were no recognized treatment options, and the mortality rate was extremely high.

View Article and Find Full Text PDF

ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13), also called von Willebrand factor (VWF) cleaving protease, acts as a moderator of VWF activity. ADAMTS13 cleaves VWF multimers, thereby reducing VWF activity in blood. When ADAMTS13 is absent (e.

View Article and Find Full Text PDF

Purpose: This work proposes a "hybrid" RF pulse design method for parallel transmit (pTx) systems to simultaneously control flip angle and root-mean-squared ( ). These pulses are generally only designed for flip angle, however, this can lead to uncontrolled , which then leads to variable magnetization transfer (MT) effects. We demonstrate the hybrid design approach for quantitative imaging where both flip angle and are important.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!